复发性-话题@MedSci

#复发性#

452篇内容 | 2500人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1909840, encodeId=9ca419098401a, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Glob Health：低成本的口服节律化疗治疗复发性转移性头颈癌, objectType=article, longId=200352, objectId=59bb200352df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59bb200352df, replyNumber=0, likeNumber=75, createdTime=2020-12-02, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59bb200352df, moduleTitle=Lancet Glob Health：低成本的口服节律化疗治疗复发性转移性头颈癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59bb200352df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909806, encodeId=4826190980683, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：Avadomide(CC-122)单药治疗难治性/复发性DLBCL的疗效和安全性, objectType=article, longId=187353, objectId=19ef18e35330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19ef18e35330, replyNumber=0, likeNumber=0, createdTime=2020-05-14, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19ef18e35330, moduleTitle=Blood：Avadomide(CC-122)单药治疗难治性/复发性DLBCL的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19ef18e35330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909788, encodeId=48e61909e880e, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：Ublituximab联合Umbralisib治疗复发性/难治性B细胞NHL和CLL的安全性评估, objectType=article, longId=180400, objectId=2b0b180400c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0b180400c6, replyNumber=0, likeNumber=75, createdTime=2020-08-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0b180400c6, moduleTitle=Blood：Ublituximab联合Umbralisib治疗复发性/难治性B细胞NHL和CLL的安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0b180400c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909805, encodeId=008f190980576, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：异基因造血干细胞移植后非复发性死亡的预后标志物, objectType=article, longId=187352, objectId=f9be18e3525e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9be18e3525e, replyNumber=0, likeNumber=72, createdTime=2020-04-24, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9be18e3525e, moduleTitle=Blood：异基因造血干细胞移植后非复发性死亡的预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9be18e3525e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909823, encodeId=6eed1909823c5, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet oncol：ARIEL3试验：Rucaparib维持治疗铂敏感性复发性卵巢癌超过2年后的探索性分析, objectType=article, longId=195598, objectId=203c1955983f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=203c1955983f, replyNumber=0, likeNumber=87, createdTime=2020-09-04, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=203c1955983f, moduleTitle=Lancet oncol：ARIEL3试验：Rucaparib维持治疗铂敏感性复发性卵巢癌超过2年后的探索性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=203c1955983f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909799, encodeId=5c811909e994d, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：BTK抑制剂acalabrutinib治疗复发性/难治性CLL/SLL, objectType=article, longId=185326, objectId=ed2f185326f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed2f185326f5, replyNumber=0, likeNumber=100, createdTime=2020-12-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed2f185326f5, moduleTitle=Blood：BTK抑制剂acalabrutinib治疗复发性/难治性CLL/SLL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed2f185326f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909827, encodeId=4aee190982e1e, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Clin cancer research：多参数MR-RET成像可预测复发性高级别神经胶质瘤对GDC-0084治疗的反应性, objectType=article, longId=197009, objectId=bd7b19e00943, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd7b19e00943, replyNumber=0, likeNumber=85, createdTime=2020-07-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd7b19e00943, moduleTitle=Clin cancer research：多参数MR-RET成像可预测复发性高级别神经胶质瘤对GDC-0084治疗的反应性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd7b19e00943)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909818, encodeId=2dda1909818f4, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Gastroenterology：粪便微生物菌群移植治疗复发性难治性梭状芽孢杆菌感染的疗效优于菲达霉素, objectType=article, longId=195042, objectId=00171950421b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00171950421b, replyNumber=0, likeNumber=79, createdTime=2020-08-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00171950421b, moduleTitle=Gastroenterology：粪便微生物菌群移植治疗复发性难治性梭状芽孢杆菌感染的疗效优于菲达霉素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00171950421b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909787, encodeId=18e41909e87e6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=安进宣布两项三期双特异性抗体BLINCYTO（靶向CD3和CD19）治疗小儿复发性急性淋巴细胞白血病患者的阳性结果, objectType=article, longId=180054, objectId=6917180054ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6917180054ef, replyNumber=0, likeNumber=70, createdTime=2019-11-13, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6917180054ef, moduleTitle=安进宣布两项三期双特异性抗体BLINCYTO（靶向CD3和CD19）治疗小儿复发性急性淋巴细胞白血病患者的阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6917180054ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909826, encodeId=8e9919098266c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Stroke：感染对急性缺血性卒中患者复发性卒中风险的影响, objectType=article, longId=196586, objectId=837d19658607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=837d19658607, replyNumber=0, likeNumber=75, createdTime=2021-03-26, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=837d19658607, moduleTitle=Stroke：感染对急性缺血性卒中患者复发性卒中风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=837d19658607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909813, encodeId=0e11190981305, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布, objectType=article, longId=193184, objectId=fb6d193184c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb6d193184c5, replyNumber=0, likeNumber=70, createdTime=2021-02-13, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6d193184c5, moduleTitle=AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6d193184c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909828, encodeId=776f1909828bd, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Clini Cancer Research：新型BTK抑制剂Zanubrutinib治疗复发性/难治性MCL, objectType=article, longId=197074, objectId=2ffd19e07469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ffd19e07469, replyNumber=0, likeNumber=68, createdTime=2020-10-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ffd19e07469, moduleTitle=Clini Cancer Research：新型BTK抑制剂Zanubrutinib治疗复发性/难治性MCL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ffd19e07469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909792, encodeId=00841909e928a, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=FDA批准Vumerity治疗复发性MS, objectType=article, longId=182202, objectId=c3c918220288, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3c918220288, replyNumber=0, likeNumber=64, createdTime=2020-05-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3c918220288, moduleTitle=FDA批准Vumerity治疗复发性MS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3c918220288)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909821, encodeId=7144190982123, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Thromb Haemost：抗磷脂抗体阳性的静脉或动脉血栓栓塞患者复发性血栓形成 , objectType=article, longId=195331, objectId=897f19533172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=897f19533172, replyNumber=0, likeNumber=0, createdTime=2021-01-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=897f19533172, moduleTitle=J Thromb Haemost：抗磷脂抗体阳性的静脉或动脉血栓栓塞患者复发性血栓形成 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=897f19533172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909797, encodeId=65461909e9745, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Rheumatol：复发性多软骨炎中影响主动脉及其分支的大血管血管炎, objectType=article, longId=185071, objectId=734c1850e14e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=734c1850e14e, replyNumber=0, likeNumber=81, createdTime=2020-09-14, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=734c1850e14e, moduleTitle=J Rheumatol：复发性多软骨炎中影响主动脉及其分支的大血管血管炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=734c1850e14e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909785, encodeId=367d1909e8556, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=2018 拉丁美洲单纯性复发性尿路感染的管理共识, objectType=article, longId=179898, objectId=33d81e98981a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33d81e98981a, replyNumber=0, likeNumber=19, createdTime=2019-11-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33d81e98981a, moduleTitle=2018 拉丁美洲单纯性复发性尿路感染的管理共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33d81e98981a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909798, encodeId=fec51909e9891, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Combretastatin A1联合阿糖胞苷治疗复发性急性髓细胞白血病成人患者中取得积极结果, objectType=article, longId=185151, objectId=1a4f18515140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a4f18515140, replyNumber=0, likeNumber=60, createdTime=2020-05-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a4f18515140, moduleTitle=Combretastatin A1联合阿糖胞苷治疗复发性急性髓细胞白血病成人患者中取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a4f18515140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909790, encodeId=12961909e9089, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=妊娠合并复发性下肢静脉血栓伴家族性血栓病史一例, objectType=article, longId=181740, objectId=c3f3181e40c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3f3181e40c2, replyNumber=0, likeNumber=74, createdTime=2020-04-19, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3f3181e40c2, moduleTitle=妊娠合并复发性下肢静脉血栓伴家族性血栓病史一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3f3181e40c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909794, encodeId=ce231909e946b, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=2019 IPOG共识建议：青少年期发作复发性呼吸道乳头状瘤病, objectType=article, longId=183158, objectId=539718315895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=539718315895, replyNumber=0, likeNumber=20, createdTime=2019-12-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=539718315895, moduleTitle=2019 IPOG共识建议：青少年期发作复发性呼吸道乳头状瘤病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=539718315895)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909808, encodeId=406f1909808a5, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=复发性多发性硬化症（MS）的治疗再迎进展：BTK抑制剂SAR442168达到中期研究的主要终点, objectType=article, longId=187657, objectId=c23618e6572f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c23618e6572f, replyNumber=0, likeNumber=111, createdTime=2020-12-04, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c23618e6572f, moduleTitle=复发性多发性硬化症（MS）的治疗再迎进展：BTK抑制剂SAR442168达到中期研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c23618e6572f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发性

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Glob Health：低成本的口服节律化疗治疗复发性转移性头颈癌

2020-12-02

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：Avadomide(CC-122)单药治疗难治性/复发性DLBCL的疗效和安全性

2020-05-14

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：Ublituximab联合Umbralisib治疗复发性/难治性B细胞NHL和CLL的安全性评估

2020-08-17

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：异基因造血干细胞移植后非复发性死亡的预后标志物

2020-04-24

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet oncol：ARIEL3试验：Rucaparib维持治疗铂敏感性复发性卵巢癌超过2年后的探索性分析

2020-09-04

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：BTK抑制剂acalabrutinib治疗复发性/难治性CLL/SLL

2020-12-11

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Clin cancer research：多参数MR-RET成像可预测复发性高级别神经胶质瘤对GDC-0084治疗的反应性

2020-07-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Gastroenterology：粪便微生物菌群移植治疗复发性难治性梭状芽孢杆菌感染的疗效优于菲达霉素

2020-08-31

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

安进宣布两项三期双特异性抗体BLINCYTO（靶向CD3和CD19）治疗小儿复发性急性淋巴细胞白血病患者的阳性结果

2019-11-13

一叶知秋 (审核中...)

前往app查看评论内容

#复发性#

Stroke：感染对急性缺血性卒中患者复发性卒中风险的影响

2021-03-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布

2021-02-13

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Clini Cancer Research：新型BTK抑制剂Zanubrutinib治疗复发性/难治性MCL

2020-10-03

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

FDA批准Vumerity治疗复发性MS

2020-05-17

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Thromb Haemost：抗磷脂抗体阳性的静脉或动脉血栓栓塞患者复发性血栓形成

2021-01-31

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Rheumatol：复发性多软骨炎中影响主动脉及其分支的大血管血管炎

2020-09-14

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

2018 拉丁美洲单纯性复发性尿路感染的管理共识

2019-11-17

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Combretastatin A1联合阿糖胞苷治疗复发性急性髓细胞白血病成人患者中取得积极结果

2020-05-17

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

妊娠合并复发性下肢静脉血栓伴家族性血栓病史一例

2020-04-19

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

2019 IPOG共识建议：青少年期发作复发性呼吸道乳头状瘤病

2019-12-31

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

复发性多发性硬化症（MS）的治疗再迎进展：BTK抑制剂SAR442168达到中期研究的主要终点

2020-12-04

科室
- - 订阅+
  - 更多科室
工具
服务